Our strategic vision is to serve the public, create value, and become an internationalized leading pharmaceutical company driven by products and talents.
We always bear in mind the social responsibility to provide the public with medicines of higher quality and more reasonable price.
To be in line with the "Healthy China 2030" initiative and the "Made in China 2050" strategy which are parts of the Chinese Dream proposed by President Xi Jinping, Gloria sets up strategies parallelly in biological medicine and chronic diseases management. With the personalized and precision medicine has become a worldwide hit, biological medicine is also the irresistible trend. Gloria is devoted to provide high-quality and affordable innovative biologics to Chinese patients. By introducing high technology and service into chronic disease products, Gloria is exploring effective solution for chronic diseases management to a new era.
In recent years, Biopharmaceutical is one of the most vigorous fields in pharmaceutical industry. In the next decade, gene therapies and innovative drugs will be launched. Chinese capabilities in R&D and industrialization of biopharmaceuticals will be greatly improved. Chemicals, Traditional Chinese Medicine and biopharmaceuticals will stand like the legs of a tripod. A new era of the rapid development biopharmaceutical in China has just arrived!
In 2015, Gloria entered into strategic collaboration agreement with Wuxi AppTec in developing innovative oncology biologics and chemical molecules. Since then Gloria started the exploration in biological industry.
Health & Wellness
As outlined in the Healthy China 2030 Plan, to enhance the country's development capabilities, the Chinese government has been improving healthcare in terms of drug affordability and healthcare access, as well as encouraging homegrown innovation to upgrade the country's healthcare sector.
Gloria is actively undertaking the social responsibility of a pharmaceutical company, and solely sponsors full-length documentary "Life-threatening", which is to educate and guide the public to have a correct understanding of reasonable and safe medication. Gloria has determined a clear direction in the strategic development of health and wellness, and is developing the company under this strategic direction in M&As, collaborations and R&D pipeline.
Site Navigation Legal declaration Contact Us
Harbin Gloria Pharmaceuticals Co., Ltd. 黑ICP備11000088;京公網安備11010102002019號
Copyright 2002 - 2016 Gloria All rights reserved